Access cutting-edge hypercholesterolemia treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Indianapolis location
Preparing your pre-screening questions…
Access hypercholesterolemia specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hypercholesterolemia treatment provided free
Check if you qualify for this hypercholesterolemia clinical trial in Indianapolis, IN
No-Cost Study Care
Local to Indianapolis
Convenient for IN residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Statins are the most cost-effective medications to lower cholesterol and cardiovascular disease (CVD) risk. However, many patients at high-risk for CVD do not accept or adhere to statins. This gap in patient's use of statins limits the full impact of these effective medications resulting in higher cholesterol levels and CVD risk. The main barriers to using statins are patients' perceived lack of benefit, excess risk of statin toxicity as well as their misperceptions of their CVD risk. Statin pharmacogenomic testing - an application of precision medicine - is a readily available, feasible, and inexpensive intervention that addresses this barrier by using genetic testing to identify the nearly 1 out of 2 patients with enhanced benefit and/or reduced risk of statin toxicity or increased risk for CVD. By communicating statin pharmacogenomic test results to Veterans at high-risk for CVD not taking statin therapy, the investigators aim to improve patients' perceptions of their risk of CVD and statins and, in turn, their acceptance of and adherence to statins to reduce their cholesterol levels and CVD risk.
Sponsor: VA Office of Research and Development
Yes, this clinical trial (NCT06568601) has an active research site in Indianapolis, IN that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for hypercholesterolemia treatment options in Indianapolis, IN, this clinical trial (NCT06568601) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hypercholesterolemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all hypercholesterolemia clinical trials near you to find additional studies recruiting in your area.
See all heart attack clinical trials recruiting in Indianapolis — not just this study.
Browse Heart Attack Trials in Indianapolis →